He predicted that the complete responders would have a simple mutational pro le in which IDH1 or IDH2 is the main driver of the disease, and expressed concern that phase III studies may be unsuccessful if they include patients with more complex mutational profiles. “We may be doomed to failu...
Moreover, the multiplication of human gingival fibroblasts and osteoblastic promotion were observed [157]. De Marco et al. enriched a collagen membrane with GO, and the product obtained was biocompatible. The authors demonstrated that GO did not leak the bulk solution and changed some membrane ...